Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1971 Aug;124(1):69-74.
doi: 10.1042/bj1240069.

Acylation of carcinogenic hydroxamic acids by carbamoyl phosphate to form reactive esters

Acylation of carcinogenic hydroxamic acids by carbamoyl phosphate to form reactive esters

P D Lotlikar et al. Biochem J. 1971 Aug.

Abstract

1. Acylation of 2-(N-hydroxyacetamido)fluorene and several other aromatic hydroxamic acids by carbamoyl phosphate was studied and compared with the acylating activity of acetyl-CoA. Acetyl phosphate was also studied. 2. The carbamoylation reaction had a pH optimum of 4.5. The reaction had a lag period of 1h and was then linear for 4h. This linearity ranged between 0.5mm- and 8mm-carbamoyl phosphate concentration. 3. At pH7.5, acetyl-CoA was the most powerful acylating agent. Acetyl phosphate was a weaker acylating agent than either of the others. 4. Among the various hydroxamic acids tested with acetyl-CoA and carbamoyl phosphate at pH.7.5, 2-(N-hydroxyacetamido)fluorene was the most reactive. On the other hand the less reactive N-hydroxy derivatives of 2-acetamidonaphthalene, 2-acetamidophenanthrene and 4-acetamidostilbene reacted severalfold more with carbamoyl phosphate than with acetyl-CoA. 5. It is suggested that carbamoylation of aromatic hydroxamic acids might be one of the final activation steps in carcinogenesis by these compounds.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1966 Sep 2;153(3740):1125-7 - PubMed
    1. Biochemistry. 1967 Jan;6(1):177-82 - PubMed
    1. Mol Pharmacol. 1968 Mar;4(2):147-54 - PubMed
    1. Biochem Biophys Res Commun. 1968 Jul 11;32(1):56-9 - PubMed
    1. Mol Pharmacol. 1968 Sep;4(5):411-26 - PubMed